<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Brain Behav</journal-id><journal-id journal-id-type="iso-abbrev">Brain Behav</journal-id><journal-id journal-id-type="doi">10.1002/(ISSN)2157-9032</journal-id><journal-id journal-id-type="publisher-id">BRB3</journal-id><journal-title-group><journal-title>Brain and Behavior</journal-title></journal-title-group><issn pub-type="epub">2162-3279</issn><publisher><publisher-name>John Wiley and Sons Inc.</publisher-name><publisher-loc>Hoboken</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27247854</article-id><article-id pub-id-type="pmc">4864053</article-id><article-id pub-id-type="doi">10.1002/brb3.484</article-id><article-id pub-id-type="publisher-id">BRB3484</article-id><article-categories><subj-group subj-group-type="overline"><subject>Original Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>Exogenous dopamine reduces <styled-content style="fixed-case">GABA</styled-content> receptor availability in the human brain</article-title><alt-title alt-title-type="left-running-head">H. C. Lou <italic>et al</italic>.</alt-title></title-group><contrib-group><contrib id="brb3484-cr-0001" contrib-type="author" corresp="yes"><name><surname>Lou</surname><given-names>Hans C.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0002" contrib-type="author"><name><surname>Rosenstand</surname><given-names>Astrid</given-names></name><xref ref-type="aff" rid="brb3484-aff-0002">
<sup>2</sup>
</xref></contrib><contrib id="brb3484-cr-0003" contrib-type="author"><name><surname>Brooks</surname><given-names>David J.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0004" contrib-type="author"><name><surname>Bender</surname><given-names>Dirk</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0005" contrib-type="author"><name><surname>Jakobsen</surname><given-names>Steen</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0006" contrib-type="author"><name><surname>Blicher</surname><given-names>Jakob U.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0007" contrib-type="author"><name><surname>Hansen</surname><given-names>Kim V.</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib><contrib id="brb3484-cr-0008" contrib-type="author"><name><surname>Møller</surname><given-names>Arne</given-names></name><xref ref-type="aff" rid="brb3484-aff-0001">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="brb3484-aff-0001"><label><sup>1</sup></label><named-content content-type="organisation-division">CFIN and Pet Center</named-content><institution>Aarhus University</institution><named-content content-type="street">Norregade 44</named-content><named-content content-type="post-code">8000</named-content><named-content content-type="city">Aarhus</named-content><country country="DK">Denmark</country></aff><aff id="brb3484-aff-0002"><label><sup>2</sup></label><institution>Dept. Ophtalmology</institution><institution>Rigshospitalet</institution><institution>Glostrup</institution><institution>Copenhagen University</institution><country country="DK">Denmark</country></aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Hans C. Lou, CFIN, Aarhus University, Norregade 44, 8000 Aarhus, Denmark. Tel: +4545811476; Fax: 78464400; E‐mail: <email>hanslou1@gmail.com</email><break></break></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>5</month><year>2016</year></pub-date><pub-date pub-type="collection"><month>7</month><year>2016</year></pub-date><volume>6</volume><issue>7</issue><issue-id pub-id-type="doi">10.1002/brb3.2016.6.issue-7</issue-id><elocation-id>e00484</elocation-id><history><date date-type="received"><day>13</day><month>11</month><year>2015</year></date><date date-type="rev-recd"><day>10</day><month>3</month><year>2016</year></date><date date-type="accepted"><day>24</day><month>3</month><year>2016</year></date></history><permissions><copyright-statement content-type="article-copyright">© 2016 The Authors. <italic>Brain and Behavior</italic> published by Wiley Periodicals, Inc.</copyright-statement><license license-type="creativeCommonsBy"><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="file:BRB3-6-e00484.pdf"></self-uri><abstract id="brb3484-abs-0001"><title><offsets xml_i="5306" xml_f="5314" txt_i="11" txt_f="19">Abstract</offsets></title><sec id="brb3484-sec-0001"><title><offsets xml_i="5356" xml_f="5366" txt_i="20" txt_f="30">Background</offsets></title><p><offsets xml_i="5377" xml_f="5575" txt_i="31" txt_f="229">While it has recently been shown that dopamine release stimulates conscious self‐monitoring through the generation of gamma oscillations in medial prefrontal/anterior cingulate cortex, and that the </offsets><styled-content style="fixed-case"><offsets xml_i="5610" xml_f="5614" txt_i="229" txt_f="233">GABA</offsets></styled-content><offsets xml_i="5631" xml_f="5828" txt_i="233" txt_f="430">ergic system is effective in producing such oscillations, interaction of the two transmitter systems has not been demonstrated in humans. We here hypothesize that dopamine challenge stimulates the </offsets><styled-content style="fixed-case"><offsets xml_i="5863" xml_f="5867" txt_i="430" txt_f="434">GABA</offsets></styled-content><offsets xml_i="5884" xml_f="5971" txt_i="434" txt_f="521"> system directly in the medial prefrontal/anterior cingulate region in the human brain.</offsets></p></sec><sec id="brb3484-sec-0002"><title><offsets xml_i="6015" xml_f="6022" txt_i="523" txt_f="530">Methods</offsets></title><p><offsets xml_i="6033" xml_f="6063" txt_i="531" txt_f="561">Positron emission tomography (</offsets><styled-content style="fixed-case"><offsets xml_i="6098" xml_f="6101" txt_i="561" txt_f="564">PET</offsets></styled-content><offsets xml_i="6118" xml_f="6129" txt_i="564" txt_f="575">) with the </offsets><styled-content style="fixed-case"><offsets xml_i="6164" xml_f="6168" txt_i="575" txt_f="579">GABA</offsets></styled-content><offsets xml_i="6185" xml_f="6195" txt_i="579" txt_f="589"> receptor </offsets><italic><offsets xml_i="6203" xml_f="6204" txt_i="589" txt_f="590">α</offsets></italic><offsets xml_i="6213" xml_f="6215" txt_i="590" txt_f="592">1/</offsets><italic><offsets xml_i="6223" xml_f="6224" txt_i="592" txt_f="593">α</offsets></italic><offsets xml_i="6233" xml_f="6251" txt_i="593" txt_f="611">5 subtype ligand [</offsets><sup><offsets xml_i="6256" xml_f="6258" txt_i="611" txt_f="613">11</offsets></sup><offsets xml_i="6264" xml_f="6307" txt_i="613" txt_f="656">C] Ro15‐4513 was used to detect changes in </offsets><styled-content style="fixed-case"><offsets xml_i="6342" xml_f="6346" txt_i="656" txt_f="660">GABA</offsets></styled-content><offsets xml_i="6363" xml_f="6459" txt_i="660" txt_f="756"> receptor availability after clinical oral doses of levodopa in a double blind controlled study.</offsets></p></sec><sec id="brb3484-sec-0003"><title><offsets xml_i="6503" xml_f="6510" txt_i="758" txt_f="765">Results</offsets></title><p><offsets xml_i="6521" xml_f="6717" txt_i="766" txt_f="962">We here provide the first direct evidence for such coupling in the cerebral cortex, in particular in the medial prefrontal anterior cingulate region, by showing that exogenous dopamine decreases [</offsets><sup><offsets xml_i="6722" xml_f="6724" txt_i="962" txt_f="964">11</offsets></sup><offsets xml_i="6730" xml_f="6803" txt_i="964" txt_f="1037">C] Ro15‐4513 binding widely in the human brain compatible with a fall in </offsets><italic><offsets xml_i="6811" xml_f="6812" txt_i="1037" txt_f="1038">α</offsets></italic><offsets xml_i="6821" xml_f="6847" txt_i="1038" txt_f="1064">1 subtype availability in </offsets><styled-content style="fixed-case"><offsets xml_i="6882" xml_f="6886" txt_i="1064" txt_f="1068">GABA</offsets></styled-content><offsets xml_i="6903" xml_f="6931" txt_i="1068" txt_f="1096"> complexes due to increased </offsets><styled-content style="fixed-case"><offsets xml_i="6966" xml_f="6970" txt_i="1096" txt_f="1100">GABA</offsets></styled-content><offsets xml_i="6987" xml_f="6997" txt_i="1100" txt_f="1110"> activity.</offsets></p></sec></abstract><kwd-group kwd-group-type="author-generated"><kwd id="brb3484-kwd-0001">Dopamine</kwd><kwd id="brb3484-kwd-0002"><styled-content style="fixed-case">GABA</styled-content></kwd><kwd id="brb3484-kwd-0003">insula</kwd><kwd id="brb3484-kwd-0004">medial prefrontal/anterior cingulate</kwd><kwd id="brb3484-kwd-0005">self‐awareness</kwd></kwd-group><funding-group><award-group><funding-source>Danish Research Council</funding-source><award-id>DFF‐1317‐00010</award-id></award-group></funding-group><counts><page-count count="5"></page-count></counts><custom-meta-group><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>component-id</meta-name><meta-value>brb3484</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>July 2016</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:4.9.2 mode:remove_FC converted:20.07.2016</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="brb3484-cit-1001">
<string-name>
<given-names>H. C.</given-names>
<surname>Lou</surname>
</string-name>, <string-name>
<given-names>D. J.</given-names>
<surname>Brooks</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Bender</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jakobsen</surname>
</string-name>, <string-name>
<given-names>J. U.</given-names>
<surname>Blicher</surname>
</string-name>, <string-name>
<given-names>K. V.</given-names>
<surname>Hansen</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Møller</surname>
</string-name>, <article-title>Exogenous dopamine reduces GABA receptor availability in the human brain</article-title>, <source>Brain and Behavior</source>, <year>2016</year>; <volume>6</volume>(<issue>7</issue>), e00484, doi: <ext-link ext-link-type="doi" xlink:href="10.1002/brb3.484">10.1002/brb3.484</ext-link>
</mixed-citation>
</p></notes></front><body><sec id="brb3484-sec-0004"><title><offsets xml_i="9195" xml_f="9207" txt_i="1119" txt_f="1131">Introduction</offsets></title><p><offsets xml_i="9218" xml_f="9324" txt_i="1132" txt_f="1238">Cognition depends on paralimbic medial prefrontal/anterior cingulate and medial parietal hubs (Lou et al. </offsets><xref rid="brb3484-bib-0013" ref-type="ref"><offsets xml_i="9368" xml_f="9372" txt_i="1238" txt_f="1242">2004</offsets></xref><offsets xml_i="9379" xml_f="9394" txt_i="1242" txt_f="1257">; Luber et al. </offsets><xref rid="brb3484-bib-0015" ref-type="ref"><offsets xml_i="9438" xml_f="9442" txt_i="1257" txt_f="1261">2012</offsets></xref><offsets xml_i="9449" xml_f="9553" txt_i="1261" txt_f="1365">) and their rich network of highly oxygen‐demanding, fast‐spiking GABAergic interneurons (Tomasi et al. </offsets><xref rid="brb3484-bib-0023" ref-type="ref"><offsets xml_i="9597" xml_f="9601" txt_i="1365" txt_f="1369">2013</offsets></xref><offsets xml_i="9608" xml_f="9787" txt_i="1369" txt_f="1548">). The network is regulated by dopamine, which in humans stimulates medial prefrontal/anterior cingulate cortex and insula, thereby generating gamma oscillations (Joensson et al. </offsets><xref rid="brb3484-bib-0008" ref-type="ref"><offsets xml_i="9831" xml_f="9835" txt_i="1548" txt_f="1552">2015</offsets></xref><offsets xml_i="9842" xml_f="9890" txt_i="1552" txt_f="1600">) essential for cognitive function (Voss et al. </offsets><xref rid="brb3484-bib-0024" ref-type="ref"><offsets xml_i="9934" xml_f="9938" txt_i="1600" txt_f="1604">2014</offsets></xref><offsets xml_i="9945" xml_f="10005" txt_i="1604" txt_f="1664">). The high oxygen requirement of these hubs (Tomasi et al. </offsets><xref rid="brb3484-bib-0023" ref-type="ref"><offsets xml_i="10049" xml_f="10053" txt_i="1664" txt_f="1668">2013</offsets></xref><offsets xml_i="10060" xml_f="10177" txt_i="1668" txt_f="1785">) makes the system vulnerable in penuria, and dysfunction is associated with disorders like ADHD (Castellanos et al. </offsets><xref rid="brb3484-bib-0002" ref-type="ref"><offsets xml_i="10221" xml_f="10225" txt_i="1785" txt_f="1789">2008</offsets></xref><offsets xml_i="10232" xml_f="10276" txt_i="1789" txt_f="1833">), autistic spectrum disorder (Assaf et al. </offsets><xref rid="brb3484-bib-0001" ref-type="ref"><offsets xml_i="10320" xml_f="10324" txt_i="1833" txt_f="1837">2010</offsets></xref><offsets xml_i="10331" xml_f="10365" txt_i="1837" txt_f="1871">), schizophrenia (Gallinat et al. </offsets><xref rid="brb3484-bib-0004" ref-type="ref"><offsets xml_i="10409" xml_f="10413" txt_i="1871" txt_f="1875">2004</offsets></xref><offsets xml_i="10420" xml_f="10447" txt_i="1875" txt_f="1902">), addiction (Romer et al. </offsets><xref rid="brb3484-bib-0017" ref-type="ref"><offsets xml_i="10491" xml_f="10495" txt_i="1902" txt_f="1906">2013</offsets></xref><offsets xml_i="10502" xml_f="10530" txt_i="1906" txt_f="1934">), and dementia (Liu et al. </offsets><xref rid="brb3484-bib-0012" ref-type="ref"><offsets xml_i="10574" xml_f="10578" txt_i="1934" txt_f="1938">2014</offsets></xref><offsets xml_i="10585" xml_f="10638" txt_i="1938" txt_f="1991">), and can follow traumatic brain injury (Ham et al. </offsets><xref rid="brb3484-bib-0006" ref-type="ref"><offsets xml_i="10682" xml_f="10686" txt_i="1991" txt_f="1995">2014</offsets></xref><offsets xml_i="10693" xml_f="10856" txt_i="1995" txt_f="2158">). It is, therefore, important to determine how the information gathered in animal models on the molecular arrangement of dopamine/GABA interaction (Sesack et al. </offsets><xref rid="brb3484-bib-0020" ref-type="ref"><offsets xml_i="10900" xml_f="10904" txt_i="2158" txt_f="2162">2003</offsets></xref><offsets xml_i="10911" xml_f="11126" txt_i="2162" txt_f="2377">) translates into the human brain. This is particularly the case for the medial prefrontal/anterior cingulate region which facilitates attention and self‐awareness. With that aim we here examined the effect of oral </offsets><sc><offsets xml_i="11130" xml_f="11131" txt_i="2377" txt_f="2378">l</offsets></sc><offsets xml_i="11136" xml_f="11464" txt_i="2378" txt_f="2706">‐dopa, a dopamine prodrug, on the activation of the GABA system in the human living cerebral cortex. The idea that dopamine release regulates cognition, including conscious experience, via the GABAergic system is based on the finding that dopamine increases confidence and accuracy of seeing rapidly presented words (Lou et al. </offsets><xref rid="brb3484-bib-0014" ref-type="ref"><offsets xml_i="11508" xml_f="11512" txt_i="2706" txt_f="2710">2011</offsets></xref><offsets xml_i="11519" xml_f="11631" txt_i="2710" txt_f="2822">), and on the fact that GABAergic interneurons are instrumental in mediating cognition in rodents (Sohal et al. </offsets><xref rid="brb3484-bib-0021" ref-type="ref"><offsets xml_i="11675" xml_f="11679" txt_i="2822" txt_f="2826">2009</offsets></xref><offsets xml_i="11686" xml_f="11890" txt_i="2826" txt_f="3030">). The hypothesis is further strengthened by the recent demonstration that dopamine release in the medial prefrontal/anterior cingulate cortex activates self‐monitoring and metacognition (Joensson et al. </offsets><xref rid="brb3484-bib-0008" ref-type="ref"><offsets xml_i="11934" xml_f="11938" txt_i="3030" txt_f="3034">2015</offsets></xref><offsets xml_i="11945" xml_f="12101" txt_i="3034" txt_f="3190">). Theoretical aspects of interaction between dopamine and GABA function have been studied in detail in a recent neurocomputational model by Lew and Tseng (</offsets><xref rid="brb3484-bib-0010" ref-type="ref"><offsets xml_i="12145" xml_f="12149" txt_i="3190" txt_f="3194">2014</offsets></xref><offsets xml_i="12156" xml_f="12158" txt_i="3194" txt_f="3196">).</offsets></p><p><offsets xml_i="12165" xml_f="12362" txt_i="3197" txt_f="3394">Direct experimental approaches have been scarce, but recently it has been demonstrated that extracellular striatal dopamine elicits opposing effects on the GABA system in rodents: dopamine release </offsets><italic><offsets xml_i="12370" xml_f="12379" txt_i="3394" txt_f="3403">activates</offsets></italic><offsets xml_i="12388" xml_f="12414" txt_i="3403" txt_f="3429"> synaptically located GABA</offsets><sub><offsets xml_i="12419" xml_f="12420" txt_i="3429" txt_f="3430">A</offsets></sub><offsets xml_i="12426" xml_f="12469" txt_i="3430" txt_f="3473"> receptor subtypes, including alpha 5, but </offsets><italic><offsets xml_i="12477" xml_f="12485" txt_i="3473" txt_f="3481">inhibits</offsets></italic><offsets xml_i="12494" xml_f="12505" txt_i="3481" txt_f="3492"> tonic GABA</offsets><sub><offsets xml_i="12510" xml_f="12511" txt_i="3492" txt_f="3493">A</offsets></sub><offsets xml_i="12517" xml_f="12573" txt_i="3493" txt_f="3549"> currents via extrasynaptically located tonic level GABA</offsets><sub><offsets xml_i="12578" xml_f="12579" txt_i="3549" txt_f="3550">A</offsets></sub><offsets xml_i="12585" xml_f="12613" txt_i="3550" txt_f="3578"> receptors (Hoerbelt et al. </offsets><xref rid="brb3484-bib-0007" ref-type="ref"><offsets xml_i="12657" xml_f="12661" txt_i="3578" txt_f="3582">2015</offsets></xref><offsets xml_i="12668" xml_f="12765" txt_i="3582" txt_f="3679">). These effects of dopamine mimic similar opposing effects of extracellular GABA (Ransom et al. </offsets><xref rid="brb3484-bib-0016" ref-type="ref"><offsets xml_i="12809" xml_f="12813" txt_i="3679" txt_f="3683">2013</offsets></xref><offsets xml_i="12820" xml_f="13035" txt_i="3683" txt_f="3898">), and are in accordance with the concept that tonic GABA currents are a homeostatic regulator responding to localized synaptic stimulation of GABA receptors by decreasing excitability in the network (Stokes et al. </offsets><xref rid="brb3484-bib-0022" ref-type="ref"><offsets xml_i="13079" xml_f="13083" txt_i="3898" txt_f="3902">2014</offsets></xref><offsets xml_i="13090" xml_f="13329" txt_i="3902" txt_f="4141">). Here, we provide the first direct in vivo evidence for such interaction in humans by showing that an exogenous dopamine challenge in physiological relevant dosage decreases GABA receptor availability, reflecting increased GABA activity.</offsets></p></sec><sec id="brb3484-sec-0005"><title><offsets xml_i="13373" xml_f="13400" txt_i="4143" txt_f="4170">Participants and Procedures</offsets></title><p><offsets xml_i="13411" xml_f="13670" txt_i="4171" txt_f="4430">The study was approved by the local ethical board (Region Midtjylland). After information given orally and in writing, and consent, nine healthy males were studied. This provides 80% power to detect a 20% reduction of anterior cingulate Ro 15‐4513 binding at </offsets><italic><offsets xml_i="13678" xml_f="13679" txt_i="4430" txt_f="4431">P</offsets></italic><offsets xml_i="13688" xml_f="13964" txt_i="4431" txt_f="4707"> = 0.05. The participants were without current medication. None had a history of mental or neurological disorders, or a history of addiction, with the exception that two had been smokers 10 and 15 years ago, respectively. Median age was 29 years, range 24–47. The PET ligand [</offsets><sup><offsets xml_i="13969" xml_f="13971" txt_i="4707" txt_f="4709">11</offsets></sup><offsets xml_i="13977" xml_f="14069" txt_i="4709" txt_f="4801">C]Ro15‐4513 is sensitive to interstitial GABA levels evidenced as a fall in availability of </offsets><italic><offsets xml_i="14077" xml_f="14078" txt_i="4801" txt_f="4802">α</offsets></italic><offsets xml_i="14087" xml_f="14155" txt_i="4802" txt_f="4870">1 subtype sites on the GABA complex for its binding (Semyano et al. </offsets><xref rid="brb3484-bib-0019" ref-type="ref"><offsets xml_i="14199" xml_f="14203" txt_i="4870" txt_f="4874">2004</offsets></xref><offsets xml_i="14210" xml_f="14226" txt_i="4874" txt_f="4890">; Stokes et al. </offsets><xref rid="brb3484-bib-0022" ref-type="ref"><offsets xml_i="14270" xml_f="14274" txt_i="4890" txt_f="4894">2014</offsets></xref><offsets xml_i="14281" xml_f="14291" txt_i="4894" txt_f="4904">). While [</offsets><sup><offsets xml_i="14296" xml_f="14298" txt_i="4904" txt_f="4906">11</offsets></sup><offsets xml_i="14304" xml_f="14334" txt_i="4906" txt_f="4936">C]Ro15‐4513 binds to both the </offsets><italic><offsets xml_i="14342" xml_f="14343" txt_i="4936" txt_f="4937">α</offsets></italic><offsets xml_i="14352" xml_f="14358" txt_i="4937" txt_f="4943">1 and </offsets><italic><offsets xml_i="14366" xml_f="14367" txt_i="4943" txt_f="4944">α</offsets></italic><offsets xml_i="14376" xml_f="14401" txt_i="4944" txt_f="4969">5 receptor subtypes, the </offsets><italic><offsets xml_i="14409" xml_f="14410" txt_i="4969" txt_f="4970">α</offsets></italic><offsets xml_i="14419" xml_f="14539" txt_i="4970" txt_f="5090">1 subtype is present at a greater density and increases in brain GABA have been shown to reduce its availability, while </offsets><italic><offsets xml_i="14547" xml_f="14548" txt_i="5090" txt_f="5091">α</offsets></italic><offsets xml_i="14557" xml_f="14693" txt_i="5091" txt_f="5227">5 binding site availability is either unaffected or mildly elevated. In the present study, it was not possible to separate signals from </offsets><italic><offsets xml_i="14701" xml_f="14702" txt_i="5227" txt_f="5228">α</offsets></italic><offsets xml_i="14711" xml_f="14717" txt_i="5228" txt_f="5234">1 and </offsets><italic><offsets xml_i="14725" xml_f="14726" txt_i="5234" txt_f="5235">α</offsets></italic><offsets xml_i="14735" xml_f="14908" txt_i="5235" txt_f="5408">5 subunits of the GABA complex as we did not have an arterial input curve so we have assumed that any decreased Ro 15‐4513 binding seen represented competitive occupancy of </offsets><italic><offsets xml_i="14916" xml_f="14917" txt_i="5408" txt_f="5409">α</offsets></italic><offsets xml_i="14926" xml_f="14977" txt_i="5409" txt_f="5460">1 sites by endogenous GABA (Lingford‐Hughes et al. </offsets><xref rid="brb3484-bib-0011" ref-type="ref"><offsets xml_i="15021" xml_f="15025" txt_i="5460" txt_f="5464">2002</offsets></xref><offsets xml_i="15032" xml_f="15034" txt_i="5464" txt_f="5466">).</offsets></p><p><offsets xml_i="15041" xml_f="15174" txt_i="5467" txt_f="5600">Each participant was studied twice in counterbalanced order with an interval of at least several days. We used PET following an oral </offsets><sc><offsets xml_i="15178" xml_f="15179" txt_i="5600" txt_f="5601">l</offsets></sc><offsets xml_i="15184" xml_f="15294" txt_i="5601" txt_f="5711">‐dopa/dopamine challenge or placebo in identical capsules given orally containing either sinemet (MSD, 100 mg </offsets><sc><offsets xml_i="15298" xml_f="15299" txt_i="5711" txt_f="5712">l</offsets></sc><offsets xml_i="15304" xml_f="15509" txt_i="5712" txt_f="5917">‐dopa plus 25 mg carbidopa) or placebo (starch). The medication was unknown to the participants and experimenters responsible for PET injection and calculation of binding potentials. The administration of </offsets><sc><offsets xml_i="15513" xml_f="15514" txt_i="5917" txt_f="5918">l</offsets></sc><offsets xml_i="15519" xml_f="15602" txt_i="5918" txt_f="6001">‐dopa or placebo was done between 30 and 45 min prior to intravenous injection of [</offsets><sup><offsets xml_i="15607" xml_f="15609" txt_i="6001" txt_f="6003">11</offsets></sup><offsets xml_i="15615" xml_f="15792" txt_i="6003" txt_f="6180">C]Ro15‐4513. This interval is based on the interval for obtaining peak plasma concentrations and clinical effects on parkinsonism after oral sinemet medication (Joensson et al. </offsets><xref rid="brb3484-bib-0008" ref-type="ref"><offsets xml_i="15836" xml_f="15840" txt_i="6180" txt_f="6184">2015</offsets></xref><offsets xml_i="15847" xml_f="15849" txt_i="6184" txt_f="6186">).</offsets></p></sec><sec id="brb3484-sec-0006"><title><offsets xml_i="15893" xml_f="15915" txt_i="6188" txt_f="6210">Results and Discussion</offsets></title><p><offsets xml_i="15926" xml_f="15947" txt_i="6211" txt_f="6232">The distribution of [</offsets><sup><offsets xml_i="15952" xml_f="15954" txt_i="6232" txt_f="6234">11</offsets></sup><offsets xml_i="15960" xml_f="16012" txt_i="6234" txt_f="6286">C]Ro15‐4513 binding with placebo is shown in Figure </offsets><xref rid="brb3484-fig-0001" ref-type="fig"><offsets xml_i="16056" xml_f="16057" txt_i="6286" txt_f="6287">1</offsets></xref><offsets xml_i="16064" xml_f="16288" txt_i="6287" txt_f="6511">. After placebo administration, the ligand is bound primarily in medial prefrontal/anterior cingulate cortex and left and right insula. The cerebellum provides a reference for nonspecific tissue binding of the tracer. After </offsets><sc><offsets xml_i="16292" xml_f="16293" txt_i="6511" txt_f="6512">l</offsets></sc><offsets xml_i="16298" xml_f="16306" txt_i="6512" txt_f="6520">‐dopa, [</offsets><sup><offsets xml_i="16311" xml_f="16313" txt_i="6520" txt_f="6522">11</offsets></sup><offsets xml_i="16319" xml_f="16541" txt_i="6522" txt_f="6744">C]Ro15‐4513 binding is reduced, which can be seen more clearly by subtraction. There is a reduction of between 5% and 20% throughout most of gray matter regions (BP 100x [placebo minus dopamine]/placebo). Small foci of BP </offsets><italic><offsets xml_i="16549" xml_f="16558" txt_i="6744" txt_f="6753">increases</offsets></italic><offsets xml_i="16567" xml_f="16757" txt_i="6753" txt_f="6943"> were, however, present in the hippocampi, possibly reflecting the high concentration of D4 dopamine receptors there which inhibit interneuron GABA release when activated (Romo‐Parra et al. </offsets><xref rid="brb3484-bib-0018" ref-type="ref"><offsets xml_i="16801" xml_f="16805" txt_i="6943" txt_f="6947">2005</offsets></xref><offsets xml_i="16812" xml_f="16814" txt_i="6947" txt_f="6949">).</offsets></p><fig fig-type="Figure" xml:lang="en" id="brb3484-fig-0001" orientation="portrait" position="float"><label><offsets xml_i="16924" xml_f="16932" txt_i="6950" txt_f="6958">Figure 1</offsets></label><caption><p><offsets xml_i="16952" xml_f="16969" txt_i="6958" txt_f="6975">Distribution of [</offsets><sup><offsets xml_i="16974" xml_f="16976" txt_i="6975" txt_f="6977">11</offsets></sup><offsets xml_i="16982" xml_f="17280" txt_i="6977" txt_f="7275">C]Ro15‐4513. After placebo, the ligand was bound primarily in medial prefrontal/anterior cingulate cortex and left and right insula. After dopamine challenge ligand binding is reduced. This is seen more clearly by subtraction, with a general reduction of between 5% and 20% throughout gray matter (</offsets><styled-content style="fixed-case"><offsets xml_i="17315" xml_f="17317" txt_i="7275" txt_f="7277">BP</offsets></styled-content><offsets xml_i="17334" xml_f="17437" txt_i="7277" txt_f="7380"> 100x [placebo minus dopamine]/placebo). In the hippocampal regions there were small foci of increased </offsets><styled-content style="fixed-case"><offsets xml_i="17472" xml_f="17474" txt_i="7380" txt_f="7382">BP</offsets></styled-content><offsets xml_i="17491" xml_f="17492" txt_i="7382" txt_f="7383">.</offsets></p></caption><graphic id="nlm-graphic-3" xlink:href="BRB3-6-e00484-g001"></graphic></fig><p><offsets xml_i="17585" xml_f="17645" txt_i="7384" txt_f="7444">Quantification using parametric modeling is shown in Figure </offsets><xref rid="brb3484-fig-0002" ref-type="fig"><offsets xml_i="17689" xml_f="17690" txt_i="7444" txt_f="7445">2</offsets></xref><offsets xml_i="17697" xml_f="17854" txt_i="7445" txt_f="7602"> for medial prefrontal/anterior cingulate region, left and right insula, cerebellum, and whole gray matter. For a composite gray matter region, a one‐sample </offsets><italic><offsets xml_i="17862" xml_f="17863" txt_i="7602" txt_f="7603">t</offsets></italic><offsets xml_i="17872" xml_f="17890" txt_i="7603" txt_f="7621">‐test showed that </offsets><sc><offsets xml_i="17894" xml_f="17895" txt_i="7621" txt_f="7622">l</offsets></sc><offsets xml_i="17900" xml_f="17951" txt_i="7622" txt_f="7673">‐dopa was associated with an 11% mean decrease in [</offsets><sup><offsets xml_i="17956" xml_f="17958" txt_i="7673" txt_f="7675">11</offsets></sup><offsets xml_i="17964" xml_f="17980" txt_i="7675" txt_f="7691">C]Ro15‐4513 BP (</offsets><italic><offsets xml_i="17988" xml_f="17989" txt_i="7691" txt_f="7692">t</offsets></italic><offsets xml_i="17998" xml_f="18030" txt_i="7692" txt_f="7724"> = −2.29, 9 degrees of freedom, </offsets><italic><offsets xml_i="18038" xml_f="18039" txt_i="7724" txt_f="7725">P</offsets></italic><offsets xml_i="18048" xml_f="18129" txt_i="7725" txt_f="7806"> = 0.048). There was a highly significant effect of regions (linear mixed model, </offsets><italic><offsets xml_i="18137" xml_f="18138" txt_i="7806" txt_f="7807">P</offsets></italic><offsets xml_i="18147" xml_f="18348" txt_i="7807" txt_f="8008"> = 0.000049). Because dopamine has previously been shown to stimulate electromagnetic activity and self‐awareness mainly in the medial prefrontal/anterior cingulate and insula regions (Joensson et al. </offsets><xref rid="brb3484-bib-0008" ref-type="ref"><offsets xml_i="18392" xml_f="18396" txt_i="8008" txt_f="8012">2015</offsets></xref><offsets xml_i="18403" xml_f="18543" txt_i="8012" txt_f="8152">), we a priori calculated BP changes in these regions separately and compared these with cerebellum and whole gray matter, using two‐tailed </offsets><italic><offsets xml_i="18551" xml_f="18552" txt_i="8152" txt_f="8153">t</offsets></italic><offsets xml_i="18561" xml_f="18613" txt_i="8153" txt_f="8205"> tests with Bonferroni corrections and a cut off at </offsets><italic><offsets xml_i="18621" xml_f="18622" txt_i="8205" txt_f="8206">P</offsets></italic><offsets xml_i="18631" xml_f="18695" txt_i="8206" txt_f="8270"> = 0.01. The BP of the GABA ligand decreased significantly with </offsets><sc><offsets xml_i="18699" xml_f="18700" txt_i="8270" txt_f="8271">l</offsets></sc><offsets xml_i="18705" xml_f="18789" txt_i="8271" txt_f="8355">‐dopa in the medial prefrontal/anterior cingulate and right insula regions (by 18%, </offsets><italic><offsets xml_i="18797" xml_f="18798" txt_i="8355" txt_f="8356">t</offsets></italic><offsets xml_i="18807" xml_f="18816" txt_i="8356" txt_f="8365"> = −3.63 </offsets><italic><offsets xml_i="18824" xml_f="18825" txt_i="8365" txt_f="8366">P</offsets></italic><offsets xml_i="18834" xml_f="18854" txt_i="8366" txt_f="8386"> = 0.0054, and 18%, </offsets><italic><offsets xml_i="18862" xml_f="18863" txt_i="8386" txt_f="8387">t</offsets></italic><offsets xml_i="18872" xml_f="18880" txt_i="8387" txt_f="8395"> = 3.85 </offsets><italic><offsets xml_i="18888" xml_f="18889" txt_i="8395" txt_f="8396">P</offsets></italic><offsets xml_i="18898" xml_f="18970" txt_i="8396" txt_f="8468"> = 0039, respectively), with no significant effect in the other regions.</offsets></p><fig fig-type="Figure" xml:lang="en" id="brb3484-fig-0002" orientation="portrait" position="float"><label><offsets xml_i="19080" xml_f="19088" txt_i="8469" txt_f="8477">Figure 2</offsets></label><caption><p><offsets xml_i="19108" xml_f="19271" txt_i="8477" txt_f="8640">Quantification in medial prefrontal/anterior cingulate region, left and right insula, cerebellum, and whole gray matter. Using parametric modeling, a decrease in [</offsets><sup><offsets xml_i="19276" xml_f="19278" txt_i="8640" txt_f="8642">11</offsets></sup><offsets xml_i="19284" xml_f="19296" txt_i="8642" txt_f="8654">C]Ro15‐4513 </offsets><styled-content style="fixed-case"><offsets xml_i="19331" xml_f="19333" txt_i="8654" txt_f="8656">BP</offsets></styled-content><offsets xml_i="19350" xml_f="19377" txt_i="8656" txt_f="8683"> is apparent overall after </offsets><sc><offsets xml_i="19381" xml_f="19382" txt_i="8683" txt_f="8684">l</offsets></sc><offsets xml_i="19387" xml_f="19441" txt_i="8684" txt_f="8738">‐dopa, except in cerebellum. For statistics, see text.</offsets></p></caption><graphic id="nlm-graphic-5" xlink:href="BRB3-6-e00484-g002"></graphic></fig><p><offsets xml_i="19534" xml_f="19592" txt_i="8739" txt_f="8797">Thus, the main findings were (1) preferential binding of [</offsets><sup><offsets xml_i="19597" xml_f="19599" txt_i="8797" txt_f="8799">11</offsets></sup><offsets xml_i="19605" xml_f="19620" txt_i="8799" txt_f="8814">C]Ro15‐4513 to </offsets><italic><offsets xml_i="19628" xml_f="19629" txt_i="8814" txt_f="8815">α</offsets></italic><offsets xml_i="19638" xml_f="19640" txt_i="8815" txt_f="8817">1/</offsets><italic><offsets xml_i="19648" xml_f="19649" txt_i="8817" txt_f="8818">α</offsets></italic><offsets xml_i="19658" xml_f="19845" txt_i="8818" txt_f="9005">5 subunits on GABA complexes in the medial prefrontal/anterior cingulate region and (2) a widespread and proportional dopamine‐induced decrease in binding potentials for the GABA ligand [</offsets><sup><offsets xml_i="19850" xml_f="19852" txt_i="9005" txt_f="9007">11</offsets></sup><offsets xml_i="19858" xml_f="19894" txt_i="9007" txt_f="9043">C]Ro15‐4513 (Lingford‐Hughes et al. </offsets><xref rid="brb3484-bib-0011" ref-type="ref"><offsets xml_i="19938" xml_f="19942" txt_i="9043" txt_f="9047">2002</offsets></xref><offsets xml_i="19949" xml_f="19951" txt_i="9047" txt_f="9049">).</offsets></p><p><offsets xml_i="19958" xml_f="20315" txt_i="9050" txt_f="9407">The present results account for the effect of dopamine in its regulation of self‐awareness via direct action on the GABA system in the medial prefrontal/anterior cingulate cortex. Similarly, the direct effect of dopamine on GABA in right insula, rather than the left, may explain the preferential role of right hemisphere in self‐recognition (Keenan et al. </offsets><xref rid="brb3484-bib-0009" ref-type="ref"><offsets xml_i="20359" xml_f="20363" txt_i="9407" txt_f="9411">2001</offsets></xref><offsets xml_i="20370" xml_f="20611" txt_i="9411" txt_f="9652">). The close cortical interaction of the two transmitter systems broadens the scope for pharmacological intervention in the many human disorders where the medial prefrontal region is dysfunctional. It may open new perspectives for treatment.</offsets></p></sec><sec id="brb3484-sec-0007"><title><offsets xml_i="20655" xml_f="20662" txt_i="9654" txt_f="9661">Methods</offsets></title><sec id="brb3484-sec-0008"><title><offsets xml_i="20704" xml_f="20730" txt_i="9662" txt_f="9688">Magnetic resonance imaging</offsets></title><p><offsets xml_i="20741" xml_f="20950" txt_i="9689" txt_f="9898">All participants were scanned with a 3T MR system pre‐registration with PET (Siemens Trio, Erlangen, Germany). A T1 MPRAGE scan (TR/TE 2420/3.7 msec, 1 mm isotropic resolution, scan time 5½ min) was performed.</offsets></p></sec><sec id="brb3484-sec-0009"><title><offsets xml_i="20994" xml_f="21019" txt_i="9900" txt_f="9925">Synthesis and purity of [</offsets><sup><offsets xml_i="21024" xml_f="21026" txt_i="9925" txt_f="9927">11</offsets></sup><offsets xml_i="21032" xml_f="21041" txt_i="9927" txt_f="9936">C]15‐4513</offsets></title><p><offsets xml_i="21052" xml_f="21053" txt_i="9937" txt_f="9938">[</offsets><sup><offsets xml_i="21058" xml_f="21060" txt_i="9938" txt_f="9940">11</offsets></sup><offsets xml_i="21066" xml_f="21144" txt_i="9940" txt_f="10018">C]15‐4513 was synthesized by the adoption of the procedure of Halldin et al. (</offsets><xref rid="brb3484-bib-0005" ref-type="ref"><offsets xml_i="21188" xml_f="21192" txt_i="10018" txt_f="10022">1992</offsets></xref><offsets xml_i="21199" xml_f="21211" txt_i="10022" txt_f="10034">). Briefly, </offsets><sup><offsets xml_i="21216" xml_f="21218" txt_i="10034" txt_f="10036">11</offsets></sup><offsets xml_i="21224" xml_f="21226" txt_i="10036" txt_f="10038">CO</offsets><sub><offsets xml_i="21231" xml_f="21232" txt_i="10038" txt_f="10039">2</offsets></sub><offsets xml_i="21238" xml_f="21330" txt_i="10039" txt_f="10131">, either produced with the PET centers GE PETtrace or IBA18/18 cyclotron, was converted to [</offsets><sup><offsets xml_i="21335" xml_f="21337" txt_i="10131" txt_f="10133">11</offsets></sup><offsets xml_i="21343" xml_f="21399" txt_i="10133" txt_f="10189">C]methyl iodide applying a GE Healthcare MeI Microlab. [</offsets><sup><offsets xml_i="21404" xml_f="21406" txt_i="10189" txt_f="10191">11</offsets></sup><offsets xml_i="21412" xml_f="21696" txt_i="10191" txt_f="10475">C]methyl iodide was trapped at room temperature in a solution of 0.3–0.5 mg Ro44‐3902 (ABX advanced biochemical compounds, Radeberg, Germany) in 0.3 mL DMF, containing 0.5–1 mg NaH (60% dispersion in mineral oil; Sigma‐Aldrich A/S, Brøndby, Denmark). After heating for 1 min at 50°C [</offsets><sup><offsets xml_i="21701" xml_f="21703" txt_i="10475" txt_f="10477">11</offsets></sup><offsets xml_i="21709" xml_f="21835" txt_i="10477" txt_f="10603">C]15‐4513 was isolated by preparative HPLC applying a 250 × 10 mm Phenomenex Luna C18(2) column and a mixture of 70 mmol/L NaH</offsets><sub><offsets xml_i="21840" xml_f="21841" txt_i="10603" txt_f="10604">2</offsets></sub><offsets xml_i="21847" xml_f="21849" txt_i="10604" txt_f="10606">PO</offsets><sub><offsets xml_i="21854" xml_f="21855" txt_i="10606" txt_f="10607">4</offsets></sub><offsets xml_i="21861" xml_f="21920" txt_i="10607" txt_f="10666"> buffer and acetonitrile (70:30). The fraction containing [</offsets><sup><offsets xml_i="21925" xml_f="21927" txt_i="10666" txt_f="10668">11</offsets></sup><offsets xml_i="21933" xml_f="22006" txt_i="10668" txt_f="10741">C]15‐4513 was collected, diluted with 50 mL of sterile water. Afterward [</offsets><sup><offsets xml_i="22011" xml_f="22013" txt_i="10741" txt_f="10743">11</offsets></sup><offsets xml_i="22019" xml_f="22083" txt_i="10743" txt_f="10807">C]15‐4513 was trapped on Water Sep‐Pak A/S, Hedehusende, Denmark</offsets><sup><offsets xml_i="22088" xml_f="22089" txt_i="10807" txt_f="10808">®</offsets></sup><offsets xml_i="22095" xml_f="22222" txt_i="10808" txt_f="10935"> C‐18 Plus light cartridge. Remaining acetonitrile was removed by flushing the Sep‐Pak cartridge with 20 mL of sterile water. [</offsets><sup><offsets xml_i="22227" xml_f="22229" txt_i="10935" txt_f="10937">11</offsets></sup><offsets xml_i="22235" xml_f="22364" txt_i="10937" txt_f="11066">C]15‐4513 was desorbed with 1 mL of sterile ethanol followed by 9 mL of saline. The final solution was sterile filtered via 0.22‐</offsets><italic><offsets xml_i="22372" xml_f="22373" txt_i="11066" txt_f="11067">μ</offsets></italic><offsets xml_i="22382" xml_f="22463" txt_i="11067" txt_f="11148">m sterile filter into a sterile product vial. This procedure yielded 1–6 GBq of [</offsets><sup><offsets xml_i="22468" xml_f="22470" txt_i="11148" txt_f="11150">11</offsets></sup><offsets xml_i="22476" xml_f="22563" txt_i="11150" txt_f="11234">C]15‐4513 within 35 min and radiochemical purities &gt;95%. Amounts of nonradioactive [</offsets><sup><offsets xml_i="22568" xml_f="22570" txt_i="11234" txt_f="11236">12</offsets></sup><offsets xml_i="22576" xml_f="22612" txt_i="11236" txt_f="11272">C]15‐4513 were in the range 0.3–3.5 </offsets><italic><offsets xml_i="22620" xml_f="22621" txt_i="11272" txt_f="11273">μ</offsets></italic><offsets xml_i="22630" xml_f="22780" txt_i="11273" txt_f="11423">g/mL (1–11 nmol/mL). Interestingly, we found increased radiolysis on the C‐18 Sep‐Pak affecting the radiochemical purity at very high radioactivities.</offsets></p></sec><sec id="brb3484-sec-0010"><title><offsets xml_i="22824" xml_f="22852" txt_i="11425" txt_f="11453">Positron emission tomography</offsets></title><p><offsets xml_i="22863" xml_f="23218" txt_i="11454" txt_f="11809">Participants were placed in the scanner with the orbitomeatal line parallel to the transaxial plane of the tomograph. Head position was monitored via laser crosshairs and video camera. In order to correct for attenuation of emitted radiation by skull and tissues, a transmission scan was acquired using a single rotating photon point source of 150 MBq of </offsets><sup><offsets xml_i="23223" xml_f="23226" txt_i="11809" txt_f="11812">137</offsets></sup><offsets xml_i="23232" xml_f="23288" txt_i="11812" txt_f="11868">Cs. Participants were pretreated with placebo or 100 mg </offsets><sc><offsets xml_i="23292" xml_f="23293" txt_i="11868" txt_f="11869">l</offsets></sc><offsets xml_i="23298" xml_f="23369" txt_i="11869" txt_f="11940">‐dopa + 25 mg carbidopa given orally to block peripheral metabolism of </offsets><sc><offsets xml_i="23373" xml_f="23374" txt_i="11940" txt_f="11941">l</offsets></sc><offsets xml_i="23379" xml_f="23506" txt_i="11941" txt_f="12068">‐dopa, thereby increasing tracer delivery to the brain. This was done 30–45 min prior to injection of 400 (range 375–425) MBq [</offsets><sup><offsets xml_i="23511" xml_f="23513" txt_i="12068" txt_f="12070">11</offsets></sup><offsets xml_i="23519" xml_f="24084" txt_i="12070" txt_f="12635">C]Ro15‐4513 through a cubital vein in 10 mL of normal saline over 30 sec. Three‐dimensional PET was recorded over 60 min, using an ECAT EXACT HR++ (CTI/Siemens 966; Siemens PET/CT Biograph, Erlangen, Germany) camera, which covers an axial field of view of 23.4 cm and provides 95 transaxial planes. The tomograph has a spatial resolution of 4.8 + 0.2 mm FWHM (transaxial, 1 cm off axis) and 5.6 mm + 0.5 mm (axial, on axis) after image reconstruction. PET and MRI were coregistered to a common MR T1 atlas from Montreal Neurological Institute (MNI) (Collins et al. </offsets><xref rid="brb3484-bib-0003" ref-type="ref"><offsets xml_i="24128" xml_f="24132" txt_i="12635" txt_f="12639">1998</offsets></xref><offsets xml_i="24139" xml_f="24226" txt_i="12639" txt_f="12726">) using PMOD (PMOD Technologies Ltd., Zurich, Switzerland). The kinetic parameters of [</offsets><sup><offsets xml_i="24231" xml_f="24233" txt_i="12726" txt_f="12728">11</offsets></sup><offsets xml_i="24239" xml_f="24332" txt_i="12728" txt_f="12821">C]Ro15‐4513 were determined by the SRTM2 method using cerebellum as reference (Wu and Carson </offsets><xref rid="brb3484-bib-0025" ref-type="ref"><offsets xml_i="24376" xml_f="24380" txt_i="12821" txt_f="12825">2002</offsets></xref><offsets xml_i="24387" xml_f="24461" txt_i="12825" txt_f="12899">). No FDR or cluster corrections were used as the regions were predefined.</offsets></p></sec></sec><sec id="brb3484-sec-0012"><title><offsets xml_i="24511" xml_f="24531" txt_i="12902" txt_f="12922">Conflict of Interest</offsets></title><p><offsets xml_i="24542" xml_f="24594" txt_i="12923" txt_f="12975">The authors declare no competing financial interest.</offsets></p></sec></body><back><ack id="brb3484-sec-0011"><title>Acknowledgments</title><p>The authors are grateful to Peter Parbo for help with PET scans, to Kim Mouridsen and Anne Nielsen for statistics, and to Henriette Vuust for help with figures. The study was supported by the Danish Research Council (research grant DFF‐1317‐00010).</p></ack><ref-list content-type="cited-references" id="brb3484-bibl-0001"><title>References</title><ref id="brb3484-bib-0001"><mixed-citation publication-type="journal" id="brb3484-cit-0001">
<string-name>
<surname>Assaf</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Jagannathan</surname>
</string-name>, <string-name>
<given-names>V. D.</given-names>
<surname>Calhoun</surname>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Miller</surname>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Stevens</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Sahl</surname>
</string-name>, et al. <year>2010</year>
<article-title>Abnormal functional connectivity of default mode sub‐networks in autism spectrum disorder patients</article-title>. <source>NeuroImage</source>
<volume>53</volume>:<fpage>247</fpage>–<lpage>256</lpage>.<pub-id pub-id-type="pmid">20621638</pub-id></mixed-citation></ref><ref id="brb3484-bib-0002"><mixed-citation publication-type="journal" id="brb3484-cit-0002">
<string-name>
<surname>Castellanos</surname>, <given-names>F. X.</given-names>
</string-name>, <string-name>
<given-names>D. S.</given-names>
<surname>Margulies</surname>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Kelly</surname>
</string-name>, <string-name>
<given-names>L. Q.</given-names>
<surname>Uddin</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Ghaffari</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Kirsch Shaw</surname>
</string-name>, et al. <year>2008</year>
<article-title>Cingulate‐precuneus interactions: a new locus of dysfunction in adult attention‐deficit/hyperactivity disorder</article-title>. <source>Biol. Psychiatry</source>
<volume>63</volume>:<fpage>332</fpage>–<lpage>337</lpage>.<pub-id pub-id-type="pmid">17888409</pub-id></mixed-citation></ref><ref id="brb3484-bib-0003"><mixed-citation publication-type="journal" id="brb3484-cit-0003">
<string-name>
<surname>Collins</surname>, <given-names>D. J.</given-names>
</string-name>, <string-name>
<given-names>A. P.</given-names>
<surname>Zijdenbos</surname>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Kollokian</surname>
</string-name>, <string-name>
<given-names>J. G.</given-names>
<surname>Sled</surname>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Kabani</surname>
</string-name>, <string-name>
<given-names>C. J.</given-names>
<surname>Holmes</surname>
</string-name>, and <string-name>
<given-names>A. C.</given-names>
<surname>Evans</surname>
</string-name>. <year>1998</year>
<article-title>Design and construction of a realistic digital brain phantom</article-title>. <source>IEEE Trans. Med. Imaging</source>
<volume>17</volume>:<fpage>463</fpage>–<lpage>468</lpage>.<pub-id pub-id-type="pmid">9735909</pub-id></mixed-citation></ref><ref id="brb3484-bib-0004"><mixed-citation publication-type="journal" id="brb3484-cit-0004">
<string-name>
<surname>Gallinat</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<given-names>G.</given-names>
<surname>Winterer</surname>
</string-name>, <string-name>
<given-names>C. S.</given-names>
<surname>Herrmann</surname>
</string-name>, and <string-name>
<given-names>D.</given-names>
<surname>Senkowski</surname>
</string-name>. <year>2004</year>
<article-title>Reduced oscillatory gamma‐band responses in unmedicated schizophrenic patients indicate impaired frontal network processing</article-title>. <source>Clin. Neurophysiol.</source>
<volume>115</volume>:<fpage>1863</fpage>–<lpage>1874</lpage>.<pub-id pub-id-type="pmid">15261865</pub-id></mixed-citation></ref><ref id="brb3484-bib-0005"><mixed-citation publication-type="journal" id="brb3484-cit-0005">
<string-name>
<surname>Halldin</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<given-names>L.</given-names>
<surname>Farde</surname>
</string-name>, <string-name>
<given-names>J. E.</given-names>
<surname>Litton</surname>
</string-name>, <string-name>
<given-names>H.</given-names>
<surname>Hall</surname>
</string-name>, and <string-name>
<given-names>G.</given-names>
<surname>Sedvall</surname>
</string-name>. <year>1992</year>
<article-title>[<sup>11</sup>C]Ro‐15‐4513, a ligand for visualization of benzodiazepine receptor binding: preparation, autoradiography, and positron emission tomography</article-title>. <source>Psychopharmacology</source>
<volume>108</volume>:<fpage>16</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">1329130</pub-id></mixed-citation></ref><ref id="brb3484-bib-0006"><mixed-citation publication-type="journal" id="brb3484-cit-0006">
<string-name>
<surname>Ham</surname>, <given-names>T. E.</given-names>
</string-name>, <string-name>
<given-names>V.</given-names>
<surname>Bonnelle</surname>
</string-name>, <string-name>
<given-names>P.</given-names>
<surname>Hellyer</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Jilka</surname>
</string-name>, <string-name>
<given-names>I. H.</given-names>
<surname>Robertson</surname>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Leech</surname>
</string-name>, and <string-name>
<given-names>D.J.</given-names>
<surname>Sharp</surname>
</string-name>. <year>2014</year>
<article-title>The neural basis of impaired self‐awareness after traumatic brain injury</article-title>. <source>Brain</source>
<volume>137</volume>:<fpage>586</fpage>–<lpage>597</lpage>.<pub-id pub-id-type="pmid">24371217</pub-id></mixed-citation></ref><ref id="brb3484-bib-0007"><mixed-citation publication-type="journal" id="brb3484-cit-0007">
<string-name>
<surname>Hoerbelt</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<given-names>T. A.</given-names>
<surname>Lindsley</surname>
</string-name>, and <string-name>
<given-names>M. W.</given-names>
<surname>Fleck</surname>
</string-name>. <year>2015</year>
<article-title>Dopamine directly modulates GABAA receptors</article-title>. <source>J. Neurosci.</source>
<volume>35</volume>:<fpage>3525</fpage>–<lpage>3536</lpage>.<pub-id pub-id-type="pmid">25716851</pub-id></mixed-citation></ref><ref id="brb3484-bib-0008"><mixed-citation publication-type="journal" id="brb3484-cit-0008">
<string-name>
<surname>Joensson</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<given-names>K. R.</given-names>
<surname>Thomsen</surname>
</string-name>, <string-name>
<given-names>L. M.</given-names>
<surname>Andersen</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Gross</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Mouridsen</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Sandberg</surname>
</string-name>, et al. <year>2015</year>
<article-title>Making sense: dopamine activates conscious self‐monitoring through medial prefrontal cortex</article-title>. <source>Hum. Brain Mapp.</source>
<volume>36</volume>:<fpage>1866</fpage>–<lpage>1877</lpage>.<pub-id pub-id-type="pmid">25627861</pub-id></mixed-citation></ref><ref id="brb3484-bib-0009"><mixed-citation publication-type="journal" id="brb3484-cit-0009">
<string-name>
<surname>Keenan</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Nelson</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>O'Connor</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Pascual Leone</surname>
</string-name>. <year>2001</year>
<article-title>Self‐recognition and the right hemisphere</article-title>. <source>Nature</source>
<volume>409</volume>:<fpage>305</fpage>.<pub-id pub-id-type="pmid">11201730</pub-id></mixed-citation></ref><ref id="brb3484-bib-0010"><mixed-citation publication-type="journal" id="brb3484-cit-0010">
<string-name>
<surname>Lew</surname>, <given-names>S. E.</given-names>
</string-name>, and <string-name>
<given-names>K. Y.</given-names>
<surname>Tseng</surname>
</string-name>. <year>2014</year>
<article-title>Dopamine modulation of GABAergic function enables network stability and input selectivity for sustaining working memory in a computational model of the prefrontal cortex</article-title>. <source>Neuropsychopharmacology</source>
<volume>39</volume>:<fpage>3067</fpage>–<lpage>3076</lpage>.<pub-id pub-id-type="pmid">24975022</pub-id></mixed-citation></ref><ref id="brb3484-bib-0011"><mixed-citation publication-type="journal" id="brb3484-cit-0011">
<string-name>
<surname>Lingford‐Hughes</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>S. P.</given-names>
<surname>Hume</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Feeney</surname>
</string-name>, <string-name>
<given-names>E.</given-names>
<surname>Hirani</surname>
</string-name>, <string-name>
<given-names>S.</given-names>
<surname>Osman</surname>
</string-name>, <string-name>
<given-names>V. J.</given-names>
<surname>Cunningham</surname>
</string-name>, et al. <year>2002</year>
<article-title>Imaging the GABA‐benzodiazepine receptor subtype containing the alpha5‐subunit in vivo with [11C]Ro15 4513 positron emission tomography</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>22</volume>:<fpage>878</fpage>–<lpage>889</lpage>.<pub-id pub-id-type="pmid">12142573</pub-id></mixed-citation></ref><ref id="brb3484-bib-0012"><mixed-citation publication-type="journal" id="brb3484-cit-0012">
<string-name>
<surname>Liu</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<given-names>C.</given-names>
<surname>Yu</surname>
</string-name>, <string-name>
<given-names>X.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Liu</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Duan</surname>
</string-name>, <string-name>
<given-names>A. F.</given-names>
<surname>Alexander‐Bloch</surname>
</string-name>, et al. <year>2014</year>
<article-title>Impaired long distance functional connectivity and weighted network architecture in Alzheimer's disease</article-title>. <source>Cereb. Cortex</source>
<volume>24</volume>:<fpage>1422</fpage>–<lpage>1435</lpage>.<pub-id pub-id-type="pmid">23314940</pub-id></mixed-citation></ref><ref id="brb3484-bib-0013"><mixed-citation publication-type="journal" id="brb3484-cit-0013">
<string-name>
<surname>Lou</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<given-names>B.</given-names>
<surname>Luber</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Crupain</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Keenan</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Nowak</surname>
</string-name>, <string-name>
<given-names>T. W.</given-names>
<surname>Kjaer</surname>
</string-name>, et al. <year>2004</year>
<article-title>Parietal cortex and representation of the mental Self</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>101</volume>:<fpage>6827</fpage>–<lpage>6832</lpage>.<pub-id pub-id-type="pmid">15096584</pub-id></mixed-citation></ref><ref id="brb3484-bib-0014"><mixed-citation publication-type="journal" id="brb3484-cit-0014">
<string-name>
<surname>Lou</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<given-names>J. C.</given-names>
<surname>Skewes</surname>
</string-name>, <string-name>
<given-names>K. R.</given-names>
<surname>Thomsen</surname>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Overgaard</surname>
</string-name>, <string-name>
<given-names>H. C.</given-names>
<surname>Lau</surname>
</string-name>, <string-name>
<given-names>K.</given-names>
<surname>Mouridsen</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Roepstorff</surname>
</string-name>. <year>2011</year>
<article-title>Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words</article-title>. <source>J. Vis.</source>
<volume>11</volume>:<fpage>1</fpage>–<lpage>6</lpage>.</mixed-citation></ref><ref id="brb3484-bib-0015"><mixed-citation publication-type="journal" id="brb3484-cit-0015">
<string-name>
<surname>Luber</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<given-names>H. C.</given-names>
<surname>Lou</surname>
</string-name>, <string-name>
<given-names>J. P.</given-names>
<surname>Keenan</surname>
</string-name>, and <string-name>
<given-names>S. H.</given-names>
<surname>Lisanby</surname>
</string-name>. <year>2012</year>
<article-title>Self‐enhancement processing in the default network: a single‐pulse TMS study</article-title>. <source>Exp. Brain Res.</source>
<volume>223</volume>:<fpage>177</fpage>–<lpage>187</lpage>.<pub-id pub-id-type="pmid">22965551</pub-id></mixed-citation></ref><ref id="brb3484-bib-0016"><mixed-citation publication-type="journal" id="brb3484-cit-0016">
<string-name>
<surname>Ransom</surname>, <given-names>C. B.</given-names>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Tao</surname>
</string-name>, <string-name>
<given-names>Y.</given-names>
<surname>Wu</surname>
</string-name>, <string-name>
<given-names>W. J.</given-names>
<surname>Spain</surname>
</string-name>, and <string-name>
<given-names>G. B.</given-names>
<surname>Richerson</surname>
</string-name>. <year>2013</year>
<article-title>Rapid regulation of tonic GABA currents in cultured rat hippocampal neurons</article-title>. <source>J. Neurophysiol.</source>
<volume>109</volume>:<fpage>803</fpage>–<lpage>812</lpage>.<pub-id pub-id-type="pmid">23114210</pub-id></mixed-citation></ref><ref id="brb3484-bib-0017"><mixed-citation publication-type="journal" id="brb3484-cit-0017">
<string-name>
<surname>Rømer Thomsen</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<given-names>M.</given-names>
<surname>Joensson</surname>
</string-name>, <string-name>
<given-names>H. C.</given-names>
<surname>Lou</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Møller</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Gross</surname>
</string-name>, <string-name>
<given-names>M. L.</given-names>
<surname>Kringelbach</surname>
</string-name>, and <string-name>
<given-names>J.P.</given-names>
<surname>Changeux</surname>
</string-name>. <year>2013</year>
<article-title>Altered paralimbic interaction in behavioral addiction</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>110</volume>:<fpage>4744</fpage>–<lpage>4749</lpage>.<pub-id pub-id-type="pmid">23487797</pub-id></mixed-citation></ref><ref id="brb3484-bib-0018"><mixed-citation publication-type="journal" id="brb3484-cit-0018">
<string-name>
<surname>Romo‐Parra</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Aceves</surname>
</string-name>, and <string-name>
<given-names>R.</given-names>
<surname>Gutières</surname>
</string-name>. <year>2005</year>
<article-title>Tonic modulation inhibition by dopamine D4 receptors in rat hippocampus</article-title>. <source>Hippocampus</source>
<volume>15</volume>:<fpage>254</fpage>–<lpage>259</lpage>.<pub-id pub-id-type="pmid">15476261</pub-id></mixed-citation></ref><ref id="brb3484-bib-0019"><mixed-citation publication-type="journal" id="brb3484-cit-0019">
<string-name>
<surname>Semyano</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<given-names>M. C.</given-names>
<surname>Walker</surname>
</string-name>, <string-name>
<given-names>D. M.</given-names>
<surname>Kullmann</surname>
</string-name>, and <string-name>
<given-names>R. A.</given-names>
<surname>Silver</surname>
</string-name>. <year>2004</year>
<article-title>Tonically active GABA A receptors: modulating gain and maintaining the tone</article-title>. <source>Trends Neurosci.</source>
<volume>27</volume>:<fpage>262</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">15111008</pub-id></mixed-citation></ref><ref id="brb3484-bib-0020"><mixed-citation publication-type="journal" id="brb3484-cit-0020">
<string-name>
<surname>Sesack</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<given-names>D. B.</given-names>
<surname>Carr</surname>
</string-name>, <string-name>
<given-names>N.</given-names>
<surname>Omelchenko</surname>
</string-name>, and <string-name>
<given-names>A.</given-names>
<surname>Pinto</surname>
</string-name>. <year>2003</year>
<article-title>Anatomical substrates for glutamate‐dopamine interactions</article-title>. <source>Ann. N. Y. Acad. Sci.</source>
<volume>1003</volume>:<fpage>36</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="pmid">14684434</pub-id></mixed-citation></ref><ref id="brb3484-bib-0021"><mixed-citation publication-type="journal" id="brb3484-cit-0021">
<string-name>
<surname>Sohal</surname>, <given-names>V. S.</given-names>
</string-name>, <string-name>
<given-names>F.</given-names>
<surname>Zhang</surname>
</string-name>, <string-name>
<given-names>O.</given-names>
<surname>Yizhar</surname>
</string-name>, and <string-name>
<given-names>K.</given-names>
<surname>Deisseroth</surname>
</string-name>. <year>2009</year>
<article-title>Parvalbumin neurons and gamma rhythms enhance cortical circuit performance</article-title>. <source>Nature</source>
<volume>459</volume>:<fpage>698</fpage>–<lpage>702</lpage>.<pub-id pub-id-type="pmid">19396159</pub-id></mixed-citation></ref><ref id="brb3484-bib-0022"><mixed-citation publication-type="journal" id="brb3484-cit-0022">
<string-name>
<surname>Stokes</surname>, <given-names>P. R.</given-names>
</string-name>, <string-name>
<given-names>J. F.</given-names>
<surname>Myers</surname>
</string-name>, <string-name>
<given-names>N. J.</given-names>
<surname>Kalk</surname>
</string-name>, <string-name>
<given-names>B. J.</given-names>
<surname>Watson</surname>
</string-name>, <string-name>
<given-names>D.</given-names>
<surname>Erritzoe</surname>
</string-name>, <string-name>
<given-names>S. J.</given-names>
<surname>Wilson</surname>
</string-name>, et al. <year>2014</year>
<article-title>Acute increases in synaptic GABA detectable in the living human brain: a [11C]Ro15‐4513 study</article-title>. <source>NeuroImage</source>
<volume>99</volume>:<fpage>158</fpage>–<lpage>165</lpage>.<pub-id pub-id-type="pmid">24844747</pub-id></mixed-citation></ref><ref id="brb3484-bib-0023"><mixed-citation publication-type="journal" id="brb3484-cit-0023">
<string-name>
<surname>Tomasi</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<given-names>G. J.</given-names>
<surname>Wang</surname>
</string-name>, and <string-name>
<given-names>N. D.</given-names>
<surname>Volkow</surname>
</string-name>. <year>2013</year>
<article-title>Energetic cost of brain functional connectivity</article-title>. <source>Proc. Natl Acad. Sci. USA</source>
<volume>1010</volume>:<fpage>13642</fpage>–<lpage>13647</lpage>.<pub-id pub-id-type="pmid">23898179</pub-id></mixed-citation></ref><ref id="brb3484-bib-0024"><mixed-citation publication-type="journal" id="brb3484-cit-0024">
<string-name>
<surname>Voss</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<given-names>R.</given-names>
<surname>Holzmann</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Hobson</surname>
</string-name>, <string-name>
<given-names>W.</given-names>
<surname>Paulus</surname>
</string-name>, <string-name>
<given-names>J.</given-names>
<surname>Koppehele‐Gossel</surname>
</string-name>, <string-name>
<given-names>A.</given-names>
<surname>Klimke</surname>
</string-name>, and <string-name>
<given-names>M.</given-names>
<surname>Nitsche</surname>
</string-name>. <year>2014</year>
<article-title>Induction of self awareness in dreams through frontal low current stimulation of gamma activity</article-title>. <source>Nat. Neurosci.</source>
<volume>17</volume>:<fpage>810</fpage>–<lpage>812</lpage>.<pub-id pub-id-type="pmid">24816141</pub-id></mixed-citation></ref><ref id="brb3484-bib-0025"><mixed-citation publication-type="journal" id="brb3484-cit-0025">
<string-name>
<surname>Wu</surname>, <given-names>Y.</given-names>
</string-name>, and <string-name>
<given-names>R. E.</given-names>
<surname>Carson</surname>
</string-name>. <year>2002</year>
<article-title>Noise reduction in the simplified reference tissue model for neuroreceptor functional imaging</article-title>. <source>J. Cereb. Blood Flow Metab.</source>
<volume>22</volume>:<fpage>1440</fpage>–<lpage>1452</lpage>.<pub-id pub-id-type="pmid">12468889</pub-id></mixed-citation></ref></ref-list></back></article>